Clinical trial
YM443 in Subjects With Functional Dyspepsia
NCT00102310 · Astellas Pharma Inc, Industry · Completed
Key facts
| NCT number | NCT00102310 |
|---|---|
| Title | YM443 in Subjects With Functional Dyspepsia |
| Official title | A Phase 2b, Multicenter, Randomized, Double-blind, Placebo-Controlled, Parallel Group, Dose Ranging Study of YM443 in Subjects With Functional Dyspepsia |
| Lead sponsor | Astellas Pharma Inc, Industry |
| Collaborators | Astellas Pharma US, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Indigestion, Nausea |
| Intervention type | Drug |
| Interventions | YM443 |
| Enrollment | 416 |
| Start date | Mar 10, 2004 |
| Primary completion | Mar 11, 2006 |
| Completion | Mar 11, 2006 |
| First posted | Jan 27, 2005 |
| Last update posted | Jan 10, 2018 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: